• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定 Annexin-A1 为口腔上皮细胞抗念珠菌效应分子。

Annexin-A1 identified as the oral epithelial cell anti-Candida effector moiety.

机构信息

Department of Oral and Craniofacial Biology, Louisiana State University Health Sciences Center and School of Dentistry, New Orleans, LA 70119, USA.

出版信息

Mol Oral Microbiol. 2010 Aug;25(4):293-304. doi: 10.1111/j.2041-1014.2010.00579.x.

DOI:10.1111/j.2041-1014.2010.00579.x
PMID:20618702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2904629/
Abstract

Innate and adaptive immunity are considered critical to protection against mucosal candidal infections. Among innate anti-Candida mechanisms, oral and vaginal epithelial cells have antifungal activity. The mechanism is fungistatic, acid-labile and includes a requirement for cell contact by intact, but not necessarily live, epithelial cells. The purpose of this study was to use the acid-labile property to further characterize the effector moiety. Surface material extracted from phosphate-buffered saline (PBS) -treated, but not acid-treated, epithelial cells significantly inhibited the growth of Candida blastoconidia in a dose-dependent manner which was abrogated by prior heat and protease treatment. Proteins extracted from PBS-treated cells bound blastoconidia and hyphae more intensely than those from acid-treated cells. Proteins from PBS-treated cells eluted from Candida revealed two unique bands of approximately 33 and 45 kDa compared with acid-treated cells. Mass spectrometry identified these proteins as Annexin-A1 and actin, respectively. Oral epithelial cells stained positive for Annexin-A1, but not actin. Western blots showed reduced Annexin-A1 in proteins from acid-treated epithelial cells compared with those from PBS-treated epithelial cells. Lastly, it was demonstrated that immunoprecipitation of Annexin-A1 from proteins extracted from PBS-treated oral epithelial cells resulted in abrogation of inhibitory activity. Taken together, these results indicate that Annexin-A1 is a strong candidate for the epithelial cell anti-Candida effector protein.

摘要

先天免疫和适应性免疫被认为是对抗黏膜念珠菌感染的关键。在先天抗念珠菌机制中,口腔和阴道上皮细胞具有抗真菌活性。其机制是抑菌、酸不稳定,包括完整但不一定存活的上皮细胞的细胞接触要求。本研究旨在利用酸不稳定特性进一步表征效应部分。从磷酸盐缓冲盐水 (PBS) 处理但未用酸处理的上皮细胞中提取的表面材料以剂量依赖性方式显著抑制芽生孢子的生长,而先前的热和蛋白酶处理则消除了这种抑制作用。与酸处理的细胞相比,从 PBS 处理的细胞中提取的蛋白质与芽生孢子和菌丝的结合更为强烈。从 PBS 处理的细胞洗脱的蛋白质与酸处理的细胞相比,显示出约 33 和 45 kDa 的两个独特条带。质谱鉴定这些蛋白质分别为膜联蛋白 A1 和肌动蛋白。口腔上皮细胞对膜联蛋白 A1 呈阳性染色,但对肌动蛋白呈阴性染色。Western blot 显示,与 PBS 处理的上皮细胞相比,酸处理的上皮细胞中的膜联蛋白 A1 减少。最后,证明从 PBS 处理的口腔上皮细胞中提取的蛋白质中免疫沉淀膜联蛋白 A1 可消除抑制活性。总之,这些结果表明膜联蛋白 A1 是上皮细胞抗念珠菌效应蛋白的有力候选者。

相似文献

1
Annexin-A1 identified as the oral epithelial cell anti-Candida effector moiety.鉴定 Annexin-A1 为口腔上皮细胞抗念珠菌效应分子。
Mol Oral Microbiol. 2010 Aug;25(4):293-304. doi: 10.1111/j.2041-1014.2010.00579.x.
2
Oral and vaginal epithelial cell anti-Candida activity is acid labile and does not require live epithelial cells.口腔和阴道上皮细胞的抗念珠菌活性对酸不稳定,且不需要活的上皮细胞。
Oral Microbiol Immunol. 2005 Aug;20(4):199-205. doi: 10.1111/j.1399-302X.2005.00212.x.
3
Potential role for a carbohydrate moiety in anti-Candida activity of human oral epithelial cells.碳水化合物部分在人口腔上皮细胞抗念珠菌活性中的潜在作用。
Infect Immun. 2001 Nov;69(11):7091-9. doi: 10.1128/IAI.69.11.7091-7099.2001.
4
Vaginal and oral epithelial cell anti-Candida activity.阴道和口腔上皮细胞抗念珠菌活性。
Infect Immun. 2002 Dec;70(12):7081-8. doi: 10.1128/IAI.70.12.7081-7088.2002.
5
Recombinant human interleukin 17A enhances the anti-Candida effect of human oral mucosal epithelial cells by inhibiting Candida albicans growth and inducing antimicrobial peptides secretion.重组人白细胞介素 17A 通过抑制白念珠菌生长和诱导抗菌肽分泌增强人口腔黏膜上皮细胞的抗念珠菌作用。
J Oral Pathol Med. 2020 Apr;49(4):320-327. doi: 10.1111/jop.12889. Epub 2019 Jun 17.
6
Candida-host interactions in HIV disease: implications for oropharyngeal candidiasis.HIV疾病中念珠菌与宿主的相互作用:对口咽念珠菌病的影响。
Adv Dent Res. 2011 Apr;23(1):45-9. doi: 10.1177/0022034511399284.
7
Potential role of high molecular weight hyaluronan in the anti-Candida activity of human oral epithelial cells.高分子量透明质酸在人口腔上皮细胞抗念珠菌活性中的潜在作用。
Med Mycol. 2007 Feb;45(1):73-9. doi: 10.1080/13693780601039607.
8
Oral epithelial cells orchestrate innate type 17 responses to through the virulence factor candidalysin.口腔上皮细胞通过真菌毒素白念珠菌素调控对 1 型固有免疫反应。
Sci Immunol. 2017 Nov 3;2(17). doi: 10.1126/sciimmunol.aam8834.
9
Candida-host interactions in HIV disease: relationships in oropharyngeal candidiasis.HIV疾病中的念珠菌与宿主相互作用:口腔念珠菌病中的关系
Adv Dent Res. 2006 Apr 1;19(1):80-4. doi: 10.1177/154407370601900116.
10
Epithelial cells and innate antifungal defense.上皮细胞与固有抗真菌防御。
J Dent Res. 2010 Jul;89(7):666-75. doi: 10.1177/0022034510368784. Epub 2010 Apr 15.

引用本文的文献

1
Host-microbe interaction paradigms in acute and recurrent vulvovaginal candidiasis.宿主-微生物相互作用模式在急性和复发性外阴阴道念珠菌病中的作用。
Cell Host Microbe. 2024 Oct 9;32(10):1654-1667. doi: 10.1016/j.chom.2024.08.018.
2
Inflammatory cytokine signalling in vulvovaginal candidiasis: a hot mess driving immunopathology.外阴阴道念珠菌病中的炎症细胞因子信号传导:引发免疫病理学的棘手问题。
Oxf Open Immunol. 2024 Aug 17;5(1):iqae010. doi: 10.1093/oxfimm/iqae010. eCollection 2024.
3
Methods Related to the Immunopathogenesis of Vulvovaginal Candidiasis and Associated Neutrophil Anergy.与外阴阴道假丝酵母菌病免疫发病机制及相关中性粒细胞无反应相关的方法。
Methods Mol Biol. 2022;2542:193-218. doi: 10.1007/978-1-0716-2549-1_14.
4
Expression Profiles of GILZ and Annexin A1 in Human Oral Candidiasis and Lichen Planus.GILZ 和 Annexin A1 在人类口腔念珠菌病和扁平苔藓中的表达谱。
Cells. 2022 Apr 27;11(9):1470. doi: 10.3390/cells11091470.
5
Applying the Host-Microbe Damage Response Framework to Pathogenesis: Current and Prospective Strategies to Reduce Damage.将宿主-微生物损伤反应框架应用于发病机制:减少损伤的当前及未来策略
J Fungi (Basel). 2020 Mar 11;6(1):35. doi: 10.3390/jof6010035.
6
Novel Mechanism behind the Immunopathogenesis of Vulvovaginal Candidiasis: "Neutrophil Anergy".外阴阴道假丝酵母菌病发病机制的新机制:“中性粒细胞无反应性”。
Infect Immun. 2018 Feb 20;86(3). doi: 10.1128/IAI.00684-17. Print 2018 Mar.
7
Vaginal Heparan Sulfate Linked to Neutrophil Dysfunction in the Acute Inflammatory Response Associated with Experimental Vulvovaginal Candidiasis.阴道硫酸乙酰肝素与实验性外阴阴道念珠菌病相关急性炎症反应中的中性粒细胞功能障碍有关。
mBio. 2017 Mar 14;8(2):e00211-17. doi: 10.1128/mBio.00211-17.
8
Divergent Annexin A1 expression in periphery and gut is associated with systemic immune activation and impaired gut immune response during SIV infection.在猴免疫缺陷病毒(SIV)感染期间,膜联蛋白A1在外周和肠道中的表达差异与全身免疫激活及肠道免疫反应受损有关。
Sci Rep. 2016 Aug 3;6:31157. doi: 10.1038/srep31157.
9
Proteomic analysis of pure human airway gland mucus reveals a large component of protective proteins.对纯人类气道腺黏液进行蛋白质组学分析,发现其中有很大一部分是保护性蛋白质。
PLoS One. 2015 Feb 23;10(2):e0116756. doi: 10.1371/journal.pone.0116756. eCollection 2015.
10
Candida albicans pathogenicity and epithelial immunity.白色念珠菌致病性与上皮免疫
PLoS Pathog. 2014 Aug 14;10(8):e1004257. doi: 10.1371/journal.ppat.1004257. eCollection 2014 Aug.

本文引用的文献

1
Annexin A1 reduces inflammatory reaction and tissue damage through inhibition of phospholipase A2 activation in adult rats following spinal cord injury.膜联蛋白A1通过抑制成年大鼠脊髓损伤后磷脂酶A2的激活来减轻炎症反应和组织损伤。
J Neuropathol Exp Neurol. 2007 Oct;66(10):932-43. doi: 10.1097/nen.0b013e3181567d59.
2
DIGE compatible labelling of surface proteins on vital cells in vitro and in vivo.体外和体内活细胞表面蛋白的差异凝胶电泳(DIGE)兼容标记
Proteomics. 2006 Jan;6(2):579-85. doi: 10.1002/pmic.200500104.
3
Oral and vaginal epithelial cell anti-Candida activity is acid labile and does not require live epithelial cells.口腔和阴道上皮细胞的抗念珠菌活性对酸不稳定,且不需要活的上皮细胞。
Oral Microbiol Immunol. 2005 Aug;20(4):199-205. doi: 10.1111/j.1399-302X.2005.00212.x.
4
Attenuation of glucocorticoid functions in an Anx-A1-/- cell line.Anx-A1基因敲除细胞系中糖皮质激素功能的减弱。
Biochem J. 2003 May 1;371(Pt 3):927-35. doi: 10.1042/BJ20021856.
5
Vaginal and oral epithelial cell anti-Candida activity.阴道和口腔上皮细胞抗念珠菌活性。
Infect Immun. 2002 Dec;70(12):7081-8. doi: 10.1128/IAI.70.12.7081-7088.2002.
6
Pathogenesis of Recurrent Vulvovaginal Candidiasis.复发性外阴阴道念珠菌病的发病机制
Curr Infect Dis Rep. 2002 Dec;4(6):514-519. doi: 10.1007/s11908-002-0038-7.
7
Growth inhibition of Candida albicans by human vaginal epithelial cells.人阴道上皮细胞对白色念珠菌的生长抑制作用
J Infect Dis. 2001 Dec 1;184(11):1489-93. doi: 10.1086/324532.
8
Potential role for a carbohydrate moiety in anti-Candida activity of human oral epithelial cells.碳水化合物部分在人口腔上皮细胞抗念珠菌活性中的潜在作用。
Infect Immun. 2001 Nov;69(11):7091-9. doi: 10.1128/IAI.69.11.7091-7099.2001.
9
Growth inhibition of Candida by human oral epithelial cells.人口腔上皮细胞对念珠菌的生长抑制作用。
J Infect Dis. 2000 Nov;182(5):1479-85. doi: 10.1086/315872. Epub 2000 Oct 9.
10
Effects of reproductive hormones on experimental vaginal candidiasis.生殖激素对实验性阴道念珠菌病的影响。
Infect Immun. 2000 Feb;68(2):651-7. doi: 10.1128/IAI.68.2.651-657.2000.